These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 10459376)

  • 1. The design of Healthcare for Communities: a study of health care delivery for alcohol, drug abuse, and mental health conditions.
    Sturm R; Gresenz C; Sherbourne C; Minnium K; Klap R; Bhattacharya J; Farley D; Young AS; Burnam MA; Wells KB
    Inquiry; 1999; 36(2):221-33. PubMed ID: 10459376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State Medicaid and MCO-CBO contracting. The George Washington University studies.
    Goplerud E; Rosenbaum S
    Behav Healthc Tomorrow; 1998 Feb; 7(1):21-7. PubMed ID: 10177768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of specialty substance abuse and mental health services in adults with substance use disorders in the community.
    Mojtabai R
    Drug Alcohol Depend; 2005 Jun; 78(3):345-54. PubMed ID: 15893166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.
    Fleming E; Lien H; Ma CT; McGuire TG
    J Ment Health Policy Econ; 2003 Mar; 6(1):3-12. PubMed ID: 14578543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public substance abuse and managed behavioral healthcare. American Managed Behavioral Healthcare Association and National Association of State Alcohol and Drug Abuse Directors, Inc.
    Behav Healthc Tomorrow; 1999 Feb; 8(1):25-30. PubMed ID: 10346117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uninsured and unstably insured: the importance of continuous insurance coverage.
    Schoen C; DesRoches C
    Health Serv Res; 2000 Apr; 35(1 Pt 2):187-206. PubMed ID: 10778809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating the delivery of privately and publicly funded substance abuse services.
    Rawson RA; Marinelli-Casey P; Washton AM
    Behav Healthc Tomorrow; 1996 Apr; 5(2):32-5, 60-1. PubMed ID: 10157573
    [No Abstract]   [Full Text] [Related]  

  • 9. Views of Australian mental health stakeholders on clients' problematic drug and alcohol use.
    Cleary M; Hunt GE; Matheson S; Walter G
    Drug Alcohol Rev; 2009 Mar; 28(2):122-8. PubMed ID: 19320696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The medical expenditure panel survey: a national information resource to support healthcare cost research and inform policy and practice.
    Cohen JW; Cohen SB; Banthin JS
    Med Care; 2009 Jul; 47(7 Suppl 1):S44-50. PubMed ID: 19536015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug treatment takes a hit. As substance abuse has surged among teens, coverage for care has been curtailed.
    Gardner J
    Mod Healthc; 1996 Oct; 26(43):66, 68, 70-2. PubMed ID: 10172795
    [No Abstract]   [Full Text] [Related]  

  • 12. Grant award to the Division of Mental Health and Developmental Disabilities, Department of Health and Social Services, State of Alaska. Center for Substance Abuse Treatment (CSAT), Center for Mental Health Services (CMHS), Substance Abuse and Mental Health Services Administration (SAMHSA), HHS. Availability of grant funds for the Division of Mental Health and Developmental Disabilities, Department of Health and Social Services, State of Alaska.
    Fed Regist; 1999 Apr; 64(73):18922-3. PubMed ID: 10558551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Private insurance and the utilization of chemical dependency treatment.
    Schmidt LA; Weisner CM
    J Subst Abuse Treat; 2005 Jan; 28(1):67-76. PubMed ID: 15723734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Providing treatment to persons with mental illness. A commentary on the Robert Wood Johnson Foundation program on chronic mental illness.
    Somers SA; Gutman MA
    Milbank Q; 1994; 72(1):27-9. PubMed ID: 8164608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is conventional wisdom wrong? Coverage for substance abuse treatment under Medicaid managed care.
    Maglione M; Ridgely MS
    J Subst Abuse Treat; 2006 Jun; 30(4):285-90. PubMed ID: 16716842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seven principles of healthcare reform. American Managed Behavioral Healthcare Association.
    Behav Healthc Tomorrow; 1994; 3(2):80, 78-9. PubMed ID: 10172258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of mental health and substance abuse services: state of the art and early results.
    Mechanic D; Schlesinger M; McAlpine DD
    Milbank Q; 1995; 73(1):19-55. PubMed ID: 7898406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance abuse treatment in the Commonwealth of Massachusetts: gaps, consequences and solutions.
    Brolin MF; Horgan C; Amaro H; Doonan M
    Issue Brief (Mass Health Policy Forum); 2005 Nov; (27):1-25. PubMed ID: 16302313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotropic drug use and expenditures among medicaid beneficiaries with and without other mental health or substance abuse services.
    Hennessy KD; Green-Hennessy S; Buck JA; Miller K
    J Nerv Ment Dis; 2003 Jul; 191(7):476-8. PubMed ID: 12891096
    [No Abstract]   [Full Text] [Related]  

  • 20. The substance abuse treatment system in the U.S. What is it? What does it do? Myths and misconceptions.
    Rawson RA; Obert JL
    Occup Med; 2002; 17(1):27-39, iii-iv. PubMed ID: 11726334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.